Pharmaceutical Industry Information Portal

HomeTagsPharmasyntez

All posts by tag

Pharmasyntez

Remdeform is included into all COVID-19 treatment regimens

Remdesivir (trade name: Remdeform, MA No. ЛП-006505 of October 14, 2020г) has been included into all in-hospital treatment regimens in the 12th version of...

Honorary guests of the Tyumen Oil and Gas Forum visited the hormonal plant of Pharmasyntez-Tyumen prepared for launch

On September 15, the Pharmasyntez-Tyumen hormonal plant under construction in Tyumen was visited by Yuri Borisov, Deputy Prime Minister of the Russian Federation, Vladimir...

The launch of R&D centre at BratskChemSyntez LLC

The R&D centre is tasked to optimise its substance manufacturing process and develop new unique molecules. The complex has modern and high-precision equipment that allows...

BratskChemSyntez and Reshetnev Siberian State University developed a training program for synthesis operators

The plant technologists and University teachers took part in the development. It will give a deeper understanding of the organic synthesis manufacturing process and...

Russian ministers visit Pharmasintez production site

In 2020 the share of the Pharmasyntez Group of Companies in the hospital procurements segment reached 7.3% in terms of volume.

EAEU GMP Certificate issued to Pharmasyntez

The Pharmasyntez Group of Companies also was one of the first in Russia to be granted a Marketing Authorization under the EAEU rules.
spot_img

Expert Articles

spot_img